Petronella O. Witteveen

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Endometrial pathology and surgical extent in ovarian adult granulosa cell tumor: associations with stage and survival.

Endometrial pathology and surgical extent in ovarian adult granulosa cell tumor: associations with stage and survival.

Journal: American journal of obstetrics and gynecology

Published: November 17, 2025

The added value of chemotherapy after secondary cytoreductive surgery in unifocal versus multifocal first recurrent epithelial ovarian cancer: A systematic review.

The added value of chemotherapy after secondary cytoreductive surgery in unifocal versus multifocal first recurrent epithelial ovarian cancer: A systematic review.

Journal: Gynecologic oncology reports

Published: May 28, 2025

Granulosa cell tumor patients presenting with acute abdomen: a case series.

Granulosa cell tumor patients presenting with acute abdomen: a case series.

Journal: Gynecologic oncology reports

Published: April 28, 2025

The Prognostic Value of FOXL2 Mutant Circulating Tumor DNA in Adult Granulosa Cell Tumor Patients.

The Prognostic Value of FOXL2 Mutant Circulating Tumor DNA in Adult Granulosa Cell Tumor Patients.

Journal: Cancers

Published: April 23, 2025

Signal transduction pathway activity in adult-type granulosa cell tumor samples.

Signal transduction pathway activity in adult-type granulosa cell tumor samples.

Journal: Gynecologic oncology

Published: December 24, 2024

Is it time to abandon staging surgery and prolonged follow-up in patients with primary adult-type granulosa cell tumor?

Is it time to abandon staging surgery and prolonged follow-up in patients with primary adult-type granulosa cell tumor?

Journal: Journal of ovarian research

Published: December 20, 2024

Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial Carcinoma.

Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial Carcinoma.

Journal: Cancers

Published: April 15, 2024

Response to Systemic Therapies in Patient-Derived Cell Lines from Primary and Recurrent Adult Granulosa Cell Tumors.

Response to Systemic Therapies in Patient-Derived Cell Lines from Primary and Recurrent Adult Granulosa Cell Tumors.

Journal: Molecular cancer therapeutics

Published: March 27, 2024

Validation of 11 added items of the outpatient version of the Utrecht Symptom Diary in patients receiving chemotherapy or targeted therapy.

Validation of 11 added items of the outpatient version of the Utrecht Symptom Diary in patients receiving chemotherapy or targeted therapy.

Journal: Journal of patient-reported outcomes

Published: February 07, 2024

PAZEC: a Dutch Gynaecological Oncology Group open-label, multicenter, phase II study of pazopanib in metastatic and locally advanced hormone-resistant endometrial cancer.

PAZEC: a Dutch Gynaecological Oncology Group open-label, multicenter, phase II study of pazopanib in metastatic and locally advanced hormone-resistant endometrial cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: January 06, 2024

WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer: A biomarker-enriched phase II study.

WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer: A biomarker-enriched phase II study.

Journal: Gynecologic oncology

Published: March 22, 2023

Response to Systemic Therapies in Ovarian Adult Granulosa Cell Tumors: A Literature Review.

Response to Systemic Therapies in Ovarian Adult Granulosa Cell Tumors: A Literature Review.

Journal: Cancers

Published: May 27, 2022

Showing 1-12 of 65

Last Updated: 09/26/2026